Neurocrine Biosciences (NBIX) Property, Plant & Equipment (Net) (2010 - 2026)
Neurocrine Biosciences (NBIX) recorded Property, Plant & Equipment (Net) of $90.5 million in Q2 2026, down 1.3% from $91.7 million a year earlier and down 0.4% from the prior quarter.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Property, Plant & Equipment (Net) (2010 - 2026) Analysis & Trends
At the end of FY2025, Neurocrine Biosciences reported Property, Plant & Equipment (Net) of $89.8 million, up 8.7% from FY2024.
- Annual Property, Plant & Equipment (Net) has increased for three straight years, with a five-year compound annual growth rate of 15.0% (FY2020 to FY2025).
- Across earlier years, Property, Plant & Equipment (Net) came in at $82.6 million in FY2024 (+16.7%), $70.8 million in FY2023 (+20.8%), $58.6 million in FY2022 (unchanged) and $58.6 million in FY2021 (+31.4%).
- Quarterly Property, Plant & Equipment (Net) has ranged from $51.1 million in Q3 2021 to $97.3 million in Q3 2025 over the past five years.
- On a year-over-year basis, Property, Plant & Equipment (Net) rose in seven of the last eight quarters, with growth averaging 12.1%.
- Peak year-over-year performance for Property, Plant & Equipment (Net) in the last five years was growth of 41.1% in Q1 2022, against a decline of 1.8% in Q2 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $90.9 million (Q1 2026), $89.8 million (Q4 2025) and $97.3 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 29.29 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 23.58 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 5.80 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 25.74 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 10.69 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 13.62 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 8.55 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 5.83 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 19.03 Bn |
| 10 | Neurocrine Biosciences | 14.55 Bn | 10.25 Bn | 935.80 Mn | 90.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 90.50 Mn |
| Mar 31, 2026 | 90.90 Mn |
| Dec 31, 2025 | 89.80 Mn |
| Sep 30, 2025 | 97.30 Mn |
| Jun 30, 2025 | 91.70 Mn |
| Mar 31, 2025 | 87.00 Mn |
| Dec 31, 2024 | 82.60 Mn |
| Sep 30, 2024 | 80.00 Mn |
| Jun 30, 2024 | 80.10 Mn |
| Mar 31, 2024 | 75.30 Mn |
| Dec 31, 2023 | 70.80 Mn |
| Sep 30, 2023 | 68.80 Mn |
| Jun 30, 2023 | 65.60 Mn |
| Mar 31, 2023 | 62.80 Mn |
| Dec 31, 2022 | 58.60 Mn |
| Sep 30, 2022 | 60.90 Mn |
| Jun 30, 2022 | 66.80 Mn |
| Mar 31, 2022 | 63.90 Mn |
| Dec 31, 2021 | 58.60 Mn |
| Sep 30, 2021 | 51.10 Mn |
API Access
Neurocrine Biosciences Property, Plant & Equipment (Net) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=property-plant-and-equipment-net&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "property-plant-and-equipment-net", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=property-plant-and-equipment-net&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();